tiprankstipranks
Trending News
More News >
Erasca (ERAS)
NASDAQ:ERAS
US Market

Compare Erasca (ERAS) vs. Competitors

Compare
333 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Erasca
$10.51
$3.25B
-23.32
459.04%
6 Buy
1 Hold
1 Sell
Moderate Buy
Arcturus Therapeutics
$7.47
$212.25M
-3.03
-57.12%
5 Buy
3 Hold
0 Sell
Moderate Buy
Arvinas Holding Company
$13.38
$859.32M
-16.66
-25.21%
6 Buy
3 Hold
0 Sell
Moderate Buy
Olema Pharmaceuticals
$25.72
$2.02B
-14.19
306.32%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.80
$920.34M
-7.53
30.13%
9 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ERAS
Erasca
10.51
8.75
497.16%
ARCT
Arcturus Therapeutics
7.47
-8.33
-52.72%
ARVN
Arvinas Holding Company
13.38
-3.72
-21.75%
OPT
OLMA
Olema Pharmaceuticals
25.72
19.76
331.54%
BCAX
Bicara Therapeutics Inc.
16.80
4.50
36.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts